Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke

Tissue-type plasminogen activator - Wikipedia

Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke – topic of research paper in Clinical medicine. Download scholarly article PDF and

Tissue Plasminogen Activator for Acute Ischemic Stroke (Alteplase, Activase®)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis

Thrombolytics for acute ischemic stroke - NNT evidence review - First10EM

Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy

Frontiers The Next Step in the Treatment of Stroke

Pharmacological brain cytoprotection in acute ischaemic stroke — renewed hope in the reperfusion era

Alteplase for Acute Ischemic Stroke - Pharmacy & Acute Care University

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

Tissue Plasminogen Activator–Induced Reperfusion Injury After Stroke Revisited

Thrombus composition and thrombolysis resistance in stroke - Research and Practice in Thrombosis and Haemostasis